Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 21, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Coronavirus Infection
Interventions
DRUG

Inhaled budesonide

adding budesonide to standard of care for pneumonia in COVID19 positive patients

Trial Locations (14)

15706

Hospital de Santiago, Santiago de Compostela

C1282AEN

"Hospital de Infecciosas Francisco Javier Muñiz", Ciudad Autonoma de Buenos Aires

C1425DQK

"CEMIC (Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno)", Ciudad Autonoma de Buenos Aires

C1272AAA

"Hospital de Rehabilitación Respiratoria María Ferrer", Ciudad Autónoma de Buenos Aires

C1408INH

"Hospital Donación Francisco Santojanni", Ciudad Autónoma de Buenos Aires

B1842

Clínica Monte Grande, Monte Grande

T4000

Hospital Centro de Salud Zenón J. Santillán, San Miguel de Tucumán

B1900

Hospital San Juan de Dios, La Plata

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

08003

Hospital del Mar, Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clinic of Barcelona, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Sara Varea

OTHER

NCT04355637 - Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia | Biotech Hunter | Biotech Hunter